Compelo Packaging is using cookies

ContinueLearn More

PCI Pharma Services plans to buy Pharmaceutical Packaging Professionals

PCI Pharma Services is planning to acquire Australia-based Pharmaceutical Packaging Professionals (PPP,) targeting Asia-Pacific growth.

PPP provides cGMP investigational product manufacturing, labelling, packaging, warehousing and distribution services for companies and research institutes undertaking clinical trials.

The company has manufacturing and warehousing plants in Melbourne, which manufacture, warehouse and distribute clinical supplies for use in Australia, New Zealand, Asia and North America.

At present, PPP is carrying out a facility expansion and upgrade to add further storage and distribution services, labeling and packaging rooms, Grade D manufacturing as well as sterile-fill manufacturing capabilities for phase II clinical studies.

The expertise of PPP supports projects across a range of temperature conditions including controlled room temperature, 2-8°C, -20°C, and -80°C environments, which extends its existing capabilities in storing, packaging, and shipping cold chain products. 

Presently, PPP has a geographic reach across US, European, and Asia Pacific customers in countries such as China, Korea, Vietnam, Sri Lanka, Taiwan, Malaysia, Thailand and New Zealand. This will allow PCI to continue its growth across the region. 

PCI Pharma Services president and CEO Bill Mitchell said: “The addition of PPP is significant for our continued global expansion. The Asia-Pacific region, including Australia, is a very attractive and growing segment in the clinical trials market. Our customers continue to seek new markets both for execution of their clinical studies as well as partners that can support them through the supply chain.” 

“This opportunity is part of our next logical phase of geographic expansion and enables us to support our customers in their long term global growth strategies.  Additionally, PPP’s highly experienced management team has a strong track record in the clinical trials marketplace and we are excited to welcome them to PCI.” 

In October last year, PCI Pharma announced the acquisition of pharmaceutical and healthcare contract packaging services provider Millmount Healthcare, based in Dublin, Ireland.

The move added four Dublin based facilities to PCI's global supply network and provided a growth platform for the company's expansion.